Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma

Name: Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic angiosarcoma, metastatic dedifferentiated liposarcoma, metastatic osteosarcoma, recurrent angiosarcoma, recurrent dedifferentiated liposarcoma, recurrent osteosarcoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 195326
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.